This vaccine is given to achieve herd immunity. All 70% of the worlds people must be vaccinated for that to be achieved. The participation of all Indonesians will greatly determine the success of this programme, he said.
Conditional use of the Sinovac Biotech Ltd vaccine is scheduled to be rolled out in the coming months with health care workers, civil servants and other at-risk populations prioritised first. It will be free for all Indonesian citizens.
For Indonesia to vaccinate two-thirds of its population, 181.5 million people, to reach herd immunity, Sadikin said the two-shot vaccine would require almost 427 million doses, including the estimate that 15% may be wasted.
Distribution will not be easy in the vast archipelago where transportation and infrastructure are inadequate in places. Health officials have cited concerns about keeping the vaccine refrigerated at the required 3646 degrees Fahrenheit to maintain its safety and effectiveness.
We know that the cold-chain distribution is not complete. This is the obstacle, Sadikin said on Tuesday. The cold-chain facilities are not enough so we are still distributing some of the vaccines. We are worried.
Indonesia received its first shipment of the Sinovac vaccines on December 6 and locked it in cold storage surrounded by armed guards. Authorities began distributing the vaccines to key locations around the country while awaiting emergency use authorisation.
The vaccine was cleared for emergency use based on clinical trial data and after the Indonesian Ulema Council declared the vaccine holy and halal.
Indonesia's vaccination programme is the first large-scale use of the Sinovac vaccine outside of China.
Indonesia has recorded more than 846,000 cases of the virus, including over 24,600 deaths.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.